the present invention also relates to a pharmaceutical or diagnostic composition according to the above, which in addition to one or more of the BPC peptide salts of the present invention, contains trehalose, in particular for peroral use, and/or pharmaceutically or diagnostically acceptable carriers, dilutents and/or additives
Glutathione S-transferase polymorphisms and their biological consequences
Because of the nature of the process, IV Pushes are supervised by specialists at all times
Save this pin for easy access
DPP-4 is not the only enzyme that can degrade GLP-1
This article explains the regulatory status of retatrutide, the principles of peptide reconstitution in clinical settings, and the serious risks associated with obtaining or self-administering unlicensed injectable compounds